N. Knape

Biased agonists of the chemokine receptor CXCR3 differentially control chemotaxis and inflammation

M. Gunn, S. Rajagopal, Jeffrey S. Smith, 2018, Science Signaling.

Can We Forgo Sentinel Lymph Node Biopsy in Women Aged ≥ 50 Years with Early-Stage Hormone-Receptor-Positive HER2-Negative Special Histologic Subtype Breast Cancer?

P. Spanheimer, M. Morrow, Philip M. Spanheimer, 2022, Annals of Surgical Oncology.

Continuous Liquid Interface Production of 3D Printed Drug-Loaded Spacers to Improve Prostate Cancer Brachytherapy Treatment.

J. Byrne, K. Wagner, S. Mecham, 2022, Acta biomaterialia.

Post-irradiation intratumoral heterogeneity modulates response to immune checkpoint inhibition therapy in a murine melanoma model

David L. Marron, K. Wagner, Yanli Qu, 2022, Neoplasia.

3D printed drug-loaded implantable devices for intraoperative treatment of cancer.

K. Wagner, Samuel B. Warner, S. Mecham, 2022, Journal of controlled release : official journal of the Controlled Release Society.

Phosphorylation barcodes direct biased chemokine signaling at CXCR3

Chia-Feng Tsai, Tujin Shi, C. Nicora, 2023, bioRxiv.

Enhancing Combined Immunotherapy and Radiotherapy through Nanomedicine

Yu Mi, C. T. Hagan, A. Wang, 2020, Bioconjugate chemistry.

Phosphorylation barcodes direct biased chemokine signaling at CXCR3.

Chia-Feng Tsai, Tujin Shi, C. Nicora, 2023, Cell Chemical Biology.